Platelet Function Tests Predicting the Efficacy and Safety of Aspirin Secondary Prevention

References

• Le Quellec S, Bordet JC, Negrier C, et al. Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response A review of the literature. Thrombosis and haemostasis. 2016 Sep 27;116(4):638–650.
   PubMed Web of Science ®Google Scholar
• Lim ST, Coughlan CA, Murphy SJ, et al. Platelet function testing in transient ischaemic attack and ischaemic stroke: a comprehensive systematic review of the literature. Platelets. 2015;26(5):402–412.
   PubMed Web of Science ®Google Scholar
• Rao Z, Zheng H, Wang F, et al. The association between high on-treatment platelet reactivity and early recurrence of ischemic events after minor stroke or TIA. Neurol Res. 2017 Aug;39(8):719–726.
   PubMed Web of Science ®Google Scholar
• Fiolaki A, Katsanos AH, Kyritsis AP, et al. High on treatment platelet reactivity to aspirin and clopidogrel in ischemic stroke: a systematic review and meta-analysis. J Neurol Sci. 2017 May 15;376:112–116.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang J, Sun H, et al. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke. Int J Clin Pharmacol Ther. 2017 Oct;55(10):789–797.
   PubMed Web of Science ®Google Scholar
• Gross L, Aradi D, Sibbing D. Platelet Function Testing in Patients on Antiplatelet Medications. Semin Thromb Hemost. 2016 Apr; 42(3):306–320.
   PubMed Web of Science ®Google Scholar
• Wang CW, Su LL, Hua QJ, et al. Aspirin resistance predicts unfavorable functional outcome in acute ischemic stroke patients. Brain Res Bull. 2018 Sep;142:176–182.
   PubMed Web of Science ®Google Scholar
• Yi X, Lin J, Zhou Q, et al. Clopidogrel Resistance Increases Rate of Recurrent Stroke and Other Vascular Events in Chinese Population. J Stroke Cerebrovasc Dis. 2016 May;25(5):1222–1228.
   PubMed Web of Science ®Google Scholar
• Lim ST, Thijs V, Murphy SJX, et al. Platelet function/reactivity testing and prediction of risk of recurrent vascular events and outcomes after TIA or ischaemic stroke: systematic review and meta-analysis. J Neurol. 2020 Oct;267(10):3021–3037.
   Google Scholar
• Shao T, Cheng Y, Jin J, et al. A comparison of three platelet function tests in ischemic stroke patients with antiplatelet therapy. J Clin Neurosci. 2020 Aug;78:91–96.
   PubMed Web of Science ®Google Scholar
• Yan AR, Naunton M. Effectiveness of Platelet Function Analysis-Guided Aspirin and/or Clopidogrel Therapy in Preventing Secondary Stroke: a Systematic Review and Meta-Analysis. J Clin Med. 2020 Dec 1;9:12.
   Google Scholar
• Eikelboom JW, Emery J, Hankey GJ. The use of platelet function assays may help to determine appropriate antiplatelet treatment options in a patient with recurrent stroke on baby aspirin: against. Stroke. 2010 Oct;41(10):2398–2399.
   PubMed Web of Science ®Google Scholar
• Fontana P, Roffi M, Reny JL. Platelet Function Test Use for Patients with Coronary Artery Disease in the Early 2020s. J Clin Med. 2020 Jan 10;9(1):194.
   Web of Science ®Google Scholar
• Paniccia R, Priora R, Liotta AA, et al. Platelet function tests: a comparative review. Vasc Health Risk Manag. 2015;11:133–148.
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011 Mar 17;12:77.
   PubMed Web of Science ®Google Scholar
• Lam H, Katyal N, Parker C, et al. Thromboelastography With Platelet Mapping is Not an Effective Measure of Platelet Inhibition in Patients With Spontaneous Intracerebral Hemorrhage on Antiplatelet Therapy. Cureus. 2018 Apr 22;10(4):e2515.
   PubMed Web of Science ®Google Scholar
• Rao Z, Zheng H, Wang F, et al. High On-Treatment Platelet Reactivity to Adenosine Diphosphate Predicts Ischemic Events of Minor Stroke and Transient Ischemic Attack. J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2074–2081.
   PubMed Web of Science ®Google Scholar
• Wu HY, Zhang C, Zhao X, et al. Residual platelet reactivity is preferred over platelet inhibition rate in monitoring antiplatelet efficacy: insights using thrombelastography. Acta Pharmacol Sin. 2020 Feb;41(2):192–197.
   PubMed Web of Science ®Google Scholar
• Shen W, Zhou JY, Gu Y, et al. Establishing a reference range for thromboelastography maximum amplitude in patients administrating with antiplatelet drugs. J Clin Lab Anal. 2020 Apr;34(4):e23144.
   PubMed Web of Science ®Google Scholar
• Giorni C, Costopoulos M, Bachelot-Loza C, et al. Platelet-mapping assay for monitoring antiplatelet therapy during mechanical circulatory support in children: a retrospective observational study. Res Pract Thromb Haemost. 2017 Jul;1(1):120–127.
   PubMed Web of Science ®Google Scholar
• Nelles NJ, Chandler WL. Platelet mapping assay interference due to platelet activation in heparinized samples. Am J Clin Pathol. 2014 Sep;142(3):331–338.
   PubMed Web of Science ®Google Scholar
• Bonello L, Tantry US, Marcucci R, et al. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010 Sep 14;56(12):919–933.
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Guyer K, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study. J Am Coll Cardiol. 2005 Nov 15;46(10):1820–1826.
   PubMed Web of Science ®Google Scholar
• Geisler T, Langer H, Wydymus M, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J. 2006 Oct;27(20):2420–2425.
   PubMed Web of Science ®Google Scholar
• Schwammenthal Y, Tsabari R, Shenkman B, et al. Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome. Cerebrovascular Dis. 2008;25(4):355–361.
   PubMed Web of Science ®Google Scholar
• Yi X, Wang C, Liu P, et al. Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population. J Neurol. 2016 Aug;263(8):1612–1619.
   PubMed Web of Science ®Google Scholar
• Breet NJ, Van Werkum JW, Bouman HJ, et al. Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. Jama. 2010 Feb 24;303(8):754–762.
   PubMed Web of Science ®Google Scholar
• Kan I, Ishibashi T, Sakuta K, et al. Preoperative Light Transmission Aggregometry Values Predict for Thromboembolic Complications After Stent-Assisted Coil Embolization. World Neurosurg. 2020 Feb;134:e731–e738.
   PubMed Web of Science ®Google Scholar
• Blais N, Pharand C, Lordkipanidze M, et al. Response to aspirin in healthy individuals Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb Haemost. 2009 Aug;102(2):404–411.
   PubMed Web of Science ®Google Scholar
• Guan J, Cong Y, Ren J, et al. Comparison between a new platelet count drop method PL-11, light transmission aggregometry, VerifyNow aspirin system and thromboelastography for monitoring short-term aspirin effects in healthy individuals. Platelets. 2015;26(1):25–30.
   PubMed Web of Science ®Google Scholar
• Mohring A, Piayda K, Dannenberg L, et al. Thromboxane Formation Assay to Identify High On-Treatment Platelet Reactivity to Aspirin. Pharmacology. 2017;100(3–4):127–130.
   PubMed Web of Science ®Google Scholar
• Althaus K, Zieger B, Bakchoul T, et al. Standardization of Light Transmission Aggregometry for Diagnosis of Platelet Disorders: an Inter-Laboratory External Quality Assessment. Thromb Haemost. 2019 Jul;119(7):1154–1161.
   PubMed Web of Science ®Google Scholar
• Crescente M, Di Castelnuovo A, Iacoviello L, et al. Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100 A systematic review. Thromb Haemost. 2008 Jan;99(1):14–26.
   PubMed Web of Science ®Google Scholar
• Linden MD, Furman MI, Frelinger AL 3rd, et al. Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost. 2007 Apr;5(4):761–765.
   PubMed Web of Science ®Google Scholar
• Bundhun PK, Janoo G, Teeluck AR, et al. Adverse clinical outcomes associated with a low dose and a high dose of aspirin following percutaneous coronary intervention: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2016 Sep 2;16(1):169.
   PubMedGoogle Scholar
• Jolly SS, Pogue J, Haladyn K, et al. Effects of aspirin dose on ischaemic events and bleeding after percutaneous coronary intervention: insights from the PCI-CURE study. Eur Heart J. 2009 Apr;30(8):900–907.
   PubMed Web of Science ®Google Scholar
• Vivas D, Bernardo E, García-Rubira JC, et al. Can resistance to aspirin be reversed after an additional dose? J Thromb Thrombolysis. 2011 Oct;32(3):356–361.
   PubMed Web of Science ®Google Scholar
• Neubauer H, Kaiser AF, Endres HG, et al. Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance–the BOchum CLopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy. BMC Med. 2011 Jan 12;9:3.
   PubMed Web of Science ®Google Scholar
• Stimpfle F, Geisler T. Impact of tailored anti-P2Y12 therapies in acute coronary syndromes. Pharmacogenomics. 2015;16(5):493–499.
   PubMed Web of Science ®Google Scholar
• Hazarbasanov D, Velchev V, Finkov B, et al. Tailoring clopidogrel dose according to multiple electrode aggregometry decreases the rate of ischemic complications after percutaneous coronary intervention. J Thromb Thrombolysis. 2012 Jul;34(1):85–90.
   PubMed Web of Science ®Google Scholar
• Bonello L, Camoin-Jau L, Arques S, et al. Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study. J Am Coll Cardiol. 2008 Apr 8;51(14):1404–1411.
   PubMed Web of Science ®Google Scholar